Ann: Ceasing to be a substantial holder from PDL, page-4

First 4 Last

Share
Profile

Follow
Investsavvy10

602 Posts.

132

05/05/20

23:07

Post #: 44452328
Share

Originally posted by Ninja Tuna: ↑

Based on PDL’s selling pattern, they will offload shares all the way til end of June. And they will buy Adairs instead as seen in change in substantial holder announcements.

significant headwinds faces Japara.
1. Cash flow is an issue, as evidenced by the fact they needed to sell land and also sell a facility and then lease it back. Cash flow issue also evidenced by the shrinking dividends ands and franking credits.

2. corona and the upcoming flu season will reduce occupancy rates throughout Australia, much similar to the last severe flu in winter that dropped occupancy to below 90%

3. too many facilities are being built when the demand is not there which is why Japara didn’t bother developing the piece of land and got out by selling. Short term demand will also be impacted by the fact that family members cannot visit aged care facilities so many will be reluctant to send loved ones there.

4. Japara consistency pays way too much to its staff north of 70% of revenue when its peers EHE and REG are much lower.
This has always been a point of concern to the market.

5. why did the CEO/MD quit now ? Surely if things are going to be great soon, he would’ve stayed on with the company.

Expand

You don't think most of what you have mentioned is not already priced into JHC?

JHC Price at posting: 52.5¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Trump is President Again: What Does This Mean for Crypto?

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

HotCopper Highlights: Your most watched and most discussed stocks this week

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

IMU

Imugene kicks off Australian trial for blood cancer treatment

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?